BSE filing, NSE: VALIANTLAB. Summary written from the filing by ALFA Finder's alert engine.
Valiant Laboratories Ltd: key numbers
- Share price
- ₹104.96
- Market cap
- ₹570.1 Cr
- Revenue (annual)
- ₹237.5 Cr
- Net profit (annual)
- ₹-3.27 Cr
- P/E (TTM)
- 35.1×Sector 43.7×
- Promoter holding
- 74.94%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Valiant Laboratories Ltd
All →Valiant Laboratories Q2 FY27 Results: Net Profit ₹0.4 Cr, Up 100.0% YoY
Valiant Laboratories Ltd reported revenue from operations of ₹116.8 Cr (+152.8% YoY) and net profit of ₹0.4 Cr (+100.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.4 Cr · +100.0% YoY
Valiant Laboratories Board Meeting Date
Valiant Laboratories will meet on 2 November 2026 to approve half-year audited results. The trading window stays closed until 4 November.
Valiant Laboratories Other Announcement
Valiant Laboratories Ltd has filed its shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulations.
Valiant Laboratories Annual General Meeting
Valiant Laboratories Limited successfully conducted its 5th Annual General Meeting on September 28, 2026, transacting 18 agenda items including financial statements and various re-appointments.
Valiant Laboratories Acquisition Worth ₹0.7 Cr
Valiant Laboratories approved acquiring up to 1.01% equity in AMPYR Renewable Energy for ₹0.70 Crore. The investment enables captive solar power for its Tarapur plant.
- Value
- ₹0.70 Cr
- Execution
- 12 months from date of board approval
Valiant Laboratories Credit Rating
Valiant Laboratories Limited received a credit rating of IND BBB/Stable/IND A2 from India Ratings and Research for bank loan facilities totaling INR 56 Crore.
- Value
- ₹56.00 Cr
Other other announcement announcements
All →Unicommerce eSolutions Other Announcement
Unicommerce cancelled its 18 November 2026 CLSA group investor meeting due to exigencies. The filing carries no financial or business event.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs reports the demise of Chairman Emeritus and Promoter Chandrakant Gogri today. He ceases to be classified as a Promoter under Regulation 31A(6)(c).
Valiant Organics Other Announcement
Valiant Organics reports the demise of Chairman Emeritus Chandrakant Gogri, a Promoter Group member. He has ceased to be a Promoter Group member under Regulation 31A(6)(c).
Aarti Industries Other Announcement
Aarti Industries announced the demise of promoter and Chairman Emeritus Chandrakant Gogri on November 15, 2026. He ceases to be a promoter under Regulation 31A(6)(c).
Aarti Drugs Other Announcement
Aarti Drugs announced the demise of promoter and Chairman Emeritus Chandrakant Gogri on November 15, 2026. He ceases to be a promoter under Regulation 31A(6)(c).
Ellenbarrie Industrial Gases Other Announcement
Ellenbarrie filed its IPO monitoring agency report for the quarter ended September 30, 2026. Proceeds were utilised as per the offer document, with no deviations.